Clinical Trial Update: Study for the Use of Alteplase in Patients Who Awaken With Stroke [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating alteplase for patients who awaken with ischemic stroke was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Alteplase (alteplase)

Snippet

Sponsor: University of California, San Diego | Conditions: Ischemic Stroke | Phase 1 | Status: WITHDRAWN